A comparison of cardiovascular problems for Rosiglitazone and Pioglitazone.
Source
D.J. Graham et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. In: JAMA 304.4 (2010), p. 411. issn: 0098-7484.
Use the following R code to directly access this dataset in R.